Weekly News Recap #Phispers
FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody

FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody

The US Food and Drug Administration (FDA) has declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat pos...

Impressions : 1815

Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn

Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn

This week, the US Food and Drug Administration (FDA) finally approved Eli Lilly’s Alzheimer’s drug donanemab after ...

Impressions : 1235

Sanofi, Roche, Sobi, Avantor – a big week for M&As; JAK inhibitors to carry heart safety, cancer warnings

This week, Phispers brings you news on Pfizer’s Xeljanz, which underwent a post-approval study. Post the study, the ...

Impressions : 2244

US, EU announce plans to fortify drug supply chains; FDA authorizes J&J’s single shot vaccine

This week, Phispers brings you news on how the pandemic has compelled both the US and the EU to focus on strengthening their su...

Impressions : 2115

Pfizer shifts timeline of Covid vaccine to November; Remdesivir slumps in WHO’s Solidarity Trial

This week, Phispers has more updates on experimental Covid-19 vaccines and treatments. Gilead’s remdesivir, which bagge...

Impressions : 59937

FDA hikes ANDA, DMF application fee; Sanofi faces charges of manslaughter in France

This week, Phispers brings you the user fee FDA will collect in FY 2021 from drug makers, CMOs and medical device makers. In ...

Impressions : 74691

Another massive explosion in a chemical plant rocks China; Lilly discloses drug pricing data for insulin

This week, Phispers brings news that J&J and Bayer have settled more than 25,000 lawsuits in the US against their blood t...

Impressions : 1936